The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-15. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
A good example of immortal cancer cells is HeLa cells, which have been used in laboratories as a model cell line since 1951. While this method of modelling human cancer in cell culture is effective and has been used for many years by scientists, it is also very imprecise. The exact changes that allow for the formation of the tumorigenic clones in the above-described experiment are not clear. Scientists addressed this question by the serial introduction of multiple mutations present in a variety of human cancers. This has led to the identification of mutation combinations that form tumorigenic cells in a variety of cell types. While the combination varies by cell type, the following alterations are required in all cases: TERT activation, loss of p53 pathway function, loss of pRb pathway function, activation of the Ras or myc proto-oncogenes, and aberration of the Protein phosphatase 2 (PP2A). That is to say, the cell has an activated telomerase, eliminating the process of death by chromosome instability or loss, absence of apoptosis-induction pathways, and continued mitosis activation. This model of cancer in cell culture accurately describes the role of telomerase in actual human tumors. Telomerase activation has been observed in ~90% of all human tumors, suggesting that the immortality conferred by telomerase plays a key role in cancer development. Of the tumors without TERT activation, most employ a separate pathway to maintain telomere length termed Alternative Lengthening of Telomeres (ALT).
== Matrix-assisted laser desorption/ionization == For matrix-assisted laser desorption/ionization (MALDI) mass spectrometry a solid or liquid sample is mixed with a matrix solution, to help the sample avoid processes such as aggregation or precipitation, while helping the sample remain stable during the ionization process. The matrix crystallizes with the sample and is then deposited on a sample plate, which can be made of a range of materials, from inert metals to inert polymers. The matrix containing the sample molecules is then transferred to the gas phase by pulsed laser irradiation. The makeup of the matrix, interactions between the sample and the matrix, and how the sample is deposited are all extremely important during sample preparation to ensure the best possible results. The selection of a matrix is the first step when preparing samples for MALDI analysis. The primary goals of the matrix are to absorb the energy from a laser, thus transferring it to the analyte molecules, and to separate the analyte molecules from each other. A consideration that should be taken into account when choosing a matrix is what type of analyte ion is expected or desired. Knowing the acidity or basicity of the analyte molecule compared with the acidity or basicity of the matrix, for example, is valuable knowledge when choosing a matrix. The matrix should not compete with the analyte molecule, so the matrix should not want to form the same type of ion as the analyte.
"In order to avoid possible health risks, the German Federal Office for Radiation Protection recommends that you minimize your personal exposure to radiation through your own initiative." As of 2016, the EMF Guideline 2016 of EUROPAEM (European Academy For Environmental Medicine) on the prevention, diagnosis and treatment of EMF-related complaints and diseases applies.
=== Sabatier reaction === Methane synthesized by Sabatier reaction is largely depleted in CH2D2 and slightly depleted in 13CH3D relative to the equilibrium state. It has been proposed that quantum tunneling effects result in the low
Sources: en.wikipedia.org
=== Cellulose sources === Nanocellulose materials can be prepared from any natural cellulose source including wood, cotton, agricultural or household wastes, algae, bacteria or tunicate. Wood, in the form of wood pulp is currently the most commonly used starting material for the industrial production of nanocellulosic materials.
== Sources == Espy, Richard (1981). The Politics of the Olympic Games: With an Epilogue, 1976–1980. University of California Press. ISBN 9780520043954. Retrieved 16 June 2013. Honey, Andrew (2000). "South Africa and the Olympic Movement" (PDF). In K.B. Wamsley; S.G. Martyn; G. H. MacDonald; R.K. Barney (eds.). Bridging Three Centuries: Intellectual Crossroads and the Modern Olympic Movement. International Symposium for Olympic Research. pp. 177–184. Retrieved 17 June 2013. Killanin, Michael Morris, Lord (1983). "V: South Africa". My Olympic Years. New York: Morrow. pp. 33–45. ISBN 978-0-688-02209-9 – via Internet Archive. Ramsamy, Sam (1991). "Apartheid and Olympism: on the Abolishment of Institutionalized Discrimination in International Sport". In Fernand Landry; Marc Landry; Magdeleine Yerlès (eds.). Sport, the Third Millennium: Proceedings of the International Symposium, Quebec City, Canada, May 21-25, 1990. Presses Université Laval. pp. 539–548. ISBN 9782763772677. Retrieved 17 June 2013.
He also places a massive £300 million long position on pound sterling, gambling that a rumored UK tax cut will raise the value of the pound. When the tax cut is realised, it has the opposite effect, putting Rishi at risk of booking millions in losses. After a disastrous casino binge, Diana agrees to cover his debts—only for Rishi’s long position to suddenly net £18 million when the tax cut is reversed alongside a significant increase in the pound interest rate. this success, however, prompts him to immediately take out another gambling loan. When Pierpoint’s stock collapses on its 150th anniversary, Rishi correctly deduces an acquisition after spotting the Barclays CEO enter the building. He interviews with Harper for a hedge fund role, only find that the job offer is a sham designed to humiliate him in front of Sweetpea and Anraj, who she has hired. On Rishi's birthday, Vinay tells Diana about Rishi’s debts and murders her in front of him, leaving Rishi traumatized. In series 4, Rishi is without a job, as he is unable to clear even basic background checks due to his wife's murder, and is revealed to have attempted suicide while living in a motel and abusing prescription drugs. Harper, who paid for his stay in rehab, gives him cash payments to surreptitiously obtain information that would aid her in shorting companies. Harper later cuts ties with Rishi after hiring Sweetpea, who is repulsed by him and refuses to work with Harper if he is involved.
Bottle warmers warm previously made and refrigerated formula. Coolers designed to fit a specific manufacturer's bottles are available to keep refrigerated formula cold. Special formula powder containers are available to store pre-measured amounts of formula so that caregivers can pre-fill bottles with sterile water and mix in the powder easily. The containers are typically designed to stack together so that multiple pre-measured amounts of formula powder may be transported as a unit. Institutions can purchase ready-to-feed formula in containers that can be used as baby bottles. The lid screws off and is replaced by a disposable teat when the formula is ready to be used. This avoids storing the formula with the teat and possibly clogging the teat holes when formula is splashed within the bottle and dries.
== Biosynthesis == Epothilone B is a 16-membered polyketide macrolactone with a methylthiazole group connected to the macrocycle by an olefinic bond. The polyketide backbone was synthesized by type I polyketide synthase (PKS) and the thiazole ring was derived from a cysteine incorporated by a nonribosomal peptide synthetase (NRPS). In this biosynthesis, both PKS and NRPS use carrier proteins, which have been post-translationally modified by phosphopantetheine groups, to join the growing chain. PKS uses coenzyme-A thioester to catalyze the reaction and modify the substrates by selectively reducing the β carbonyl to the hydroxyl (Ketoreductase, KR), the alkene (Dehydratase, DH), and the alkane (Enoyl Reductase, ER). PKS-I can also methylate the α carbon of the substrate. NRPS, on the other hand, uses amino acids activated on the enzyme as aminoacyl adenylates. Unlike PKS, epimerization, N-methylation, and heterocycle formation occurs in the NRPS enzyme.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.